OLYMPUSby New Odyssey
Menu
SEC registrant · CIK 0000810509

NAVIDEA BIOPHARMACEUTICALS, INC.

NAVIDEA BIOPHARMACEUTICALS, INC. (CIK 0000810509, EIN 31-1080091) reported revenue of $65,652 for FY2022 (2022-01-01 to 2022-12-31) and net income of -$15.18 million (-$15,177,153) for FY2022 (2022-01-01 to 2022-12-31), as filed in its 10-K filed 2023-03-27 (accession 0001437749-23-008054).

Figures are as filed with the SEC in XBRL, in whole US dollars unless stated, for the company's own fiscal years (fiscal year ends December 31).

Data as of Oct 21, 2026 (Olympus publication) · Markdown version

  • Values are as filed by the company in its 10-K and 10-Q XBRL data. When a later filing restates a value, the latest filed value is shown and the first reported value is noted.

Identifiers

As published in the company's EDGAR submissions record.

IdentifierValue
CIK0000810509
EIN31-1080091
SIC industry code2835 In Vitro & In Vivo Diagnostic Substances
State or country of incorporationDE
Fiscal year endDecember 31
Filer categoryNon-accelerated filer<br>Smaller reporting company
Entity typeoperating
Olympus entity IDorg_1frzwpdzmbz8gfzhea61en64h3
  • The EIN is the one the filer gave to EDGAR. The SEC does not verify it; Olympus checks only that it has nine digits and a prefix the IRS assigns.

Latest annual financial metrics

The latest annual value of each standardised metric, with the filing it was taken from.

MetricValueFiscal periodPeriodFormFiledAccession numberXBRL concept
Revenue$65,652FY20222022-01-01 to 2022-12-3110-K2023-03-270001437749-23-008054Revenues
Net income-$15,177,153FY20222022-01-01 to 2022-12-3110-K2023-03-270001437749-23-008054NetIncomeLoss
Total assets$4,371,606FY2022as of 2022-12-3110-K2023-03-270001437749-23-008054Assets
Total liabilities$12,514,916FY2022as of 2022-12-3110-K2023-03-270001437749-23-008054Liabilities
Stockholders' equity-$8,435,828FY2022as of 2022-12-3110-K2023-03-270001437749-23-008054StockholdersEquity
Operating cash flow-$8,986,570FY20222022-01-01 to 2022-12-3110-K2023-03-270001437749-23-008054NetCashProvidedByUsedInOperatingActivities
Diluted earnings per share-$0.4 per shareFY20212021-01-01 to 2021-12-3110-K2022-03-280001437749-22-007390EarningsPerShareBasicAndDiluted
Shares outstanding32,851,252 sharesFY2022as of 2023-03-1710-K2023-03-270001437749-23-008054EntityCommonStockSharesOutstanding
  • Accession numbers link to the filing's index on SEC EDGAR.

Revenue and net income history

Every annual revenue and net income value served for fiscal years 2013-2022, newest first, each with its filing.

MetricFiscal periodPeriodValueFormFiledAccession number
RevenueFY20222022-01-01 to 2022-12-31$65,65210-K2023-03-270001437749-23-008054
RevenueFY20212021-01-01 to 2021-12-31$531,51310-K2023-03-270001437749-23-008054
RevenueFY20202020-01-01 to 2020-12-31$915,01310-K2022-03-280001437749-22-007390
RevenueFY20192019-01-01 to 2019-12-31$657,82610-K2021-03-260001437749-21-007329
RevenueFY20182018-01-01 to 2018-12-31$1,169,35110-K2020-03-180001437749-20-005567
RevenueFY20172017-01-01 to 2017-12-31$1,810,43710-K2019-03-150001437749-19-005086
RevenueFY20162016-01-01 to 2016-12-31$4,971,63410-K2018-03-150001437749-18-004756
RevenueFY20152015-01-01 to 2015-12-31$3,013,36110-K2018-03-150001437749-18-004756
RevenueFY20142014-01-01 to 2014-12-31$6,274,84910-K2017-03-310001654954-17-002915
RevenueFY20132013-01-01 to 2013-12-31$1,130,63010-K2016-03-230001564590-16-015173
Net incomeFY20222022-01-01 to 2022-12-31-$15,177,15310-K2023-03-270001437749-23-008054
Net incomeFY20212021-01-01 to 2021-12-31-$11,730,92710-K2023-03-270001437749-23-008054
Net incomeFY20202020-01-01 to 2020-12-31-$10,721,69110-K2022-03-280001437749-22-007390
Net incomeFY20192019-01-01 to 2019-12-31-$10,948,21410-K2021-03-260001437749-21-007329
Net incomeFY20182018-01-01 to 2018-12-31-$16,114,31610-K2020-03-180001437749-20-005567
Net incomeFY20172017-01-01 to 2017-12-31$74,945,85610-K2019-03-150001437749-19-005086
Net incomeFY20162016-01-01 to 2016-12-31-$14,309,03110-K2017-03-310001654954-17-002915
Net incomeFY20152015-01-01 to 2015-12-31-$27,563,53510-K2017-03-310001654954-17-002915
Net incomeFY20142014-01-01 to 2014-12-31-$35,726,66910-K2017-03-310001654954-17-002915
Net incomeFY20132013-01-01 to 2013-12-31-$42,699,45810-K2015-03-160000810509-15-000003
  • Revenue for FY2016 was restated: first reported as $21,969,706 (accession 0001654954-17-002915, filed 2017-03-31).
  • Revenue for FY2015 was restated: first reported as $13,249,307 (accession 0001564590-16-015173, filed 2016-03-23).

Recent 10-K and 10-Q filings

The 12 most recent 10-K, 10-Q and amendment filings in EDGAR, newest first.

FormFiledPeriod of reportAccession numberDocument
10-Q2023-11-142023-09-300001437749-23-032052navb20230930_10q.htm
10-Q2023-08-112023-06-300001437749-23-023319navb20230630_10q.htm
10-Q2023-05-112023-03-310001437749-23-013972navb20230331_10q.htm
10-K2023-03-272022-12-310001437749-23-008054navb20221231_10k.htm
10-Q2022-11-142022-09-300001437749-22-027321navb20220930_10q.htm
10-Q2022-08-152022-06-300001437749-22-020558navb20220630_10q.htm
10-Q2022-05-162022-03-310001437749-22-012668navb20220331_10q.htm
10-K2022-03-282021-12-310001437749-22-007390navb20211231_10k.htm
10-Q2021-11-122021-09-300001437749-21-026457navb20210930_10q.htm
10-Q2021-08-122021-06-300001437749-21-019756navb20210630_10q.htm
10-Q2021-05-132021-03-310001437749-21-012043navb20210331_10q.htm
10-K2021-03-262020-12-310001437749-21-007329navb20201231_10k.htm

Identifier registry

The company's identifiers in the Olympus identifier registry, each with how it was linked and its source.

SchemeValueHow linkedSourcePublished
SEC Central Index Key (CIK) · OLY-US-SEC-CIK0000810509published by the sourcedata.sec.gov/submissions/CIK0000810509.json2026-10-21
Employer Identification Number (EIN) · US-EIN31-1080091published by the sourcedata.sec.gov/submissions/CIK0000810509.json2026-10-21

Former names

NameFromTo
NEOPROBE CORP1995-02-102011-12-30

Sources

  • EDGAR submissions (nightly bulk archive) (company profile and filings) — U.S. Securities and Exchange Commission. EDGAR snapshot sha256:f7d2a4f18cb91aae, source date 2026-10-20. https://data.sec.gov/submissions/CIK0000810509.json
  • EDGAR XBRL company facts (nightly bulk archive) (financial metrics) — U.S. Securities and Exchange Commission. EDGAR snapshot sha256:01e4045aa34d7224, source date 2026-10-20. https://data.sec.gov/api/xbrl/companyfacts/CIK0000810509.json
  • Published by Olympus on Oct 21, 2026.
  • Source data: U.S. Securities and Exchange Commission (EDGAR). Values are as filed by the registrant; Olympus does not audit or adjust them.
  • Olympus is not affiliated with or endorsed by the U.S. Securities and Exchange Commission.

Get this data from the API

The same figures, with provenance on every value, from the API (free API key, reference) or from an AI agent through the Olympus MCP server.

curl
curl -s "https://api.olympus.new-odyssey.com/v1/sec/companies/0000810509" -H "X-API-Key: $OLYMPUS_API_KEY"

curl -s "https://api.olympus.new-odyssey.com/v1/sec/companies/0000810509/financials" -H "X-API-Key: $OLYMPUS_API_KEY"

curl -s "https://api.olympus.new-odyssey.com/v1/sec/companies/0000810509/filings?limit=12" -H "X-API-Key: $OLYMPUS_API_KEY"
MCP tool call
get_sec_company_financials {"cik":"810509"}

On SEC EDGAR

About this data